A Study of LFB-IGSC in Patients with Primary-Immunodeficiency

• Research type

  Research Study

• Full title

  A Multicentre Phase III Study on the Efficacy, Safety and Pharmacokinetics of LFB-IgSC in Patients with Primary Immunodeficiency (PID) Syndromes

• IRAS ID

  134195

• Contact name

  Hilary Longhurst

• Contact email

  Hilary.Longhurst@bartshealth.nhs.uk

• Sponsor organisation

  LFB Biotechnologies

• Eudract number

  2013-000620-34

• ISRCTN Number

  N/A

• REC name

  London - South East Research Ethics Committee

• REC reference

  13/LO/1692

• Date of REC Opinion

  10 Jan 2014

• REC opinion

  Further Information Favourable Opinion